- Report
- October 2024
- 192 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- September 2024
- 110 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- February 2025
- 200 Pages
Global
From €4304EUR$4,490USD£3,597GBP
- Report
- October 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- September 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- May 2024
- 213 Pages
Global
From €4789EUR$4,995USD£4,001GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3106EUR$3,240USD£2,595GBP
€3451EUR$3,600USD£2,884GBP
- Report
- January 2024
- 189 Pages
Global
From €7190EUR$7,500USD£6,008GBP
- Report
- April 2024
- 30 Pages
Global
From €3116EUR$3,250USD£2,603GBP
- Report
- January 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 90 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
India
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 150 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 90 Pages
Africa, Middle East
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
Japan
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 70 Pages
Italy
From €4554EUR$4,750USD£3,805GBP

Jardiance is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to lower blood sugar levels. Jardiance is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels.
Jardiance is part of a larger market of endocrine and metabolic disorder drugs, which includes medications used to treat conditions such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can help to improve overall health and quality of life.
Companies in the Jardiance market include Boehringer Ingelheim, Merck, and Eli Lilly. Show Less Read more